BROMOPRIDE

Details

Stereochemistry	ACHIRAL
Molecular Formula	C14H22BrN3O2
Molecular Weight	344.247
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CCN(CC)CCNC(=O)C1=CC(Br)=C(N)C=C1OC

InChI

InChIKey=GIYAQDDTCWHPPL-UHFFFAOYSA-N

InChI=1S/C14H22BrN3O2/c1-4-18(5-2)7-6-17-14(19)10-8-11(15)12(16)9-13(10)20-3/h8-9H,4-7,16H2,1-3H3,(H,17,19)

HIDE SMILES / InChI

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14871277 | http://www.medicinanet.com.br/bula/1015/bromopan.htm

Bromopride is a dopamine D2 receptor blocker. Bromopride exerts is a gastrointestinal prokinetic exploited clinically for the management of motor disorders of the upper gastrointestinal tract, including functional dyspepsia, gastric stasis of various origins and emesis.

CNS Activity

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Dopamine D2 receptor 297 Target ID: CHEMBL339 Sources: https://www.ncbi.nlm.nih.gov/pubmed/14871277 \| https://www.ncbi.nlm.nih.gov/pubmed/7823770	Antagonist 2778
cholinesterase activity 5 Target ID: GO:0004104 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7823770	Inhibitor 8297

Conditions

Condition	Modality	Targets	Highest Phase	Product
Dyspepsia 11 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28778685	Primary		Approved 8429	Bromopan Approved Use Principais: distúrbios digestivos psicossomáticos ad senectude e da estafa mental. Discinesias gastroduodenais e biliares. Colopatias espasmódicas. Enxaquecas e mal-estar de origem celíaca. Náuseas. Vômitos. Anorexia. Particulares: exames radiológicos do tubo digestivo. Preparação de explorações endoscópicas. Vômitos anestésicos. Soluços. Meteorismo abdominal pós-operatório. Manifestações digestivas após a aplicação de radioterapia.

PubMed

Title	Date	PubMed

Patents

Sample Use Guides

In Vivo Use Guide

Capsules: 40-60 mg/day Oral solution: 40-60 mg/day (adults), 0.5-1 mg/kg (children)

Route of Administration: Oral

In Vitro Use Guide

Bromopride effects on cholinesterase activity in plasma, striatum, duodenum and ileum of adult male rats were measured for drug concentrations ranging from 0.006 to 3.134 microM. Bromopride can inhibit cholinesterase activity in all tissues studied,

Name

Type

Language

BROMOPRIDE

Official Name

English

BROMOPRIDE [MI]

Common Name

English

bromopride [INN]

Common Name

English

NSC-758391

Code

English

MOVIPRIDE

Brand Name

English

BROMOPRIDE [MART.]

Common Name

English

4-AMINO-5-BROMO-N-(2-(DIETHYLAMINO)ETHYL)-O-ANISAMIDE

Common Name

English

Bromopride [WHO-DD]

Common Name

English

Classification Tree Code System Code

WHO-ATC

A03FA04